The activity of serum glutamate dehydrogenase (EC 1.4.1. 3) has become a valid biochemical parameter for the differential diagnosis of hepatic diseases (1) (2) (3) . For this purpose, the enzyme is determined routinely on a large scale at our hospital. Therefore, a mechanized procedure was evaluated for its reliability. The activity of this enzyme was measured under "optimized" conditions according to SCHMIDT (4) and the recommendations of the German Society for Clinical Chemistry (5). This procedure includes the determination of a sample blank value. For purposes of simplification we have investigated whether this blank could be subtracted from the result as a fixed value.
Materials and Methods
Triethanolamine, NADH (Trisodium salt) and ADP were purchased from C. F. Boehringer (D-68 Mannheim), control sera from , bovine albumin (purest) from Behringwerke AG and all other chemicals p. a. from E. Merck AG Figure 1 . Drift effects can be neglected and need not be monitored because of the nature of the kinetic procedure. No drift of blank or standard (6) was observed in batches containing up to 60 samples. The detection limit was derived from the interbatch variation (n = 15) of water samples Nos 5, 6, 9 and 10 ( Fig. 1 ) as the threefold standard deviation according to KAISER (7). The mean was calculated from all 4 values. The interaction from low to high concentrations (Q^ and from high to low concentrations (Q 2 ) was determined as recently described (8) and expressed as the percent interaction coefficient (Q = 100 · q; for the explantion. of q see Fig. 1 ). A sequence of 5 identical samples (Enzatrol, lot No. 233A) with a relatively low activity of glutamate dehydrogenase (6 /1) was followed by 5 identical sera with a high activity (110 U/l) and finally by 5 samples with the low activity. Sera with a high glutamate dehydrogenase activity were prepared by mixing 5 ml .Enzatrol (Lot No. ET 233A) with 50/til diluted glutamate dehydrogenase suspension (2.5 ml Enzatrol + 10 μΐ glutamate dehydrogenase No. 15140 from Boehringer-Mannheim). Monitrol Π solutions containing various glutamate dehydrogenase activities were obtained similarily. The temperature at 25.0 ± 0.1°C was checked in the cuvettes with a tastotherm instrument (Braun, D-6 Frankfurt) calibrated against a thermometer. For the determination of the precision 3 identical serum samples (x a , Xb, Xc) are analyzed daily ( Fig. 1 the precision from-day-to-day from the Xb -(or the x c ) values
Results and Discussion
The procedure described above for the mechanized determination of the glutamate dehydrogenase activity in human serum samples is precise enough for clinical diagnostic purposes (Tab. 1). Under these experimental conditions an activity of up to 30 U/l can be measured and up to 60 U/l if the recorder paper runs at 2 cm per minute. Samples with higher activities must be diluted 1+4. The detection limit was 0.3 U/l (x = 0.26; η = 4). The activity of the glutamate dehydrogenase was determined in serum samples from 97 patients by the automated and by a manual procedure. The data obtained with both methods show a good correlation (Fig. 2 ). Since.a relatively large sample volume is chosen, interaction effects have to be considered. The percent carry over from high to low activities (Q 2 ) was 1.5 ± 0.4
Tab. 1 The precision of the mechanized determination of the glutamate dehydrogenase (G1DH) activity. Monitrol II (3 ml) was mixed with 50 μ\ enzyme suspension containing various glutamate dehydrogenase (G1DH) activities as described under methods Bidist. H 2 O was substituted for 2-oxoglutarate determined on 10 different days, and could not be detected from low to high activities (Qj). Using a procedure recently developed (8), a so called "interaction-safe range" was calculated (Fig. 3 ) which demonstrated that carry over effects can be neglected between samples containing less than 60 U/l. If a sample must be diluted because of its high activity, the analysis of the following sample must also be repeated. In the test procedure proposed by SCHMIDT (4) an individual blank value has to be determined in which the substrate (2-oxoglutarate) is replaced by distilled water. The distribution of 1626 blank values from various patients shown in Figure 4 is not Gaussian. The median is at 0.3 U/l. 93% of all values are not higher than 0.5 and 97% not higher than 0.8. For routine purposes we suggest that 0.3 U/l be subtracted from each activity found in human sera and that the determination of individual blank values be omitted. However, it must be determined whether the discrimination at the borderline between normal and patho- logical is not altered by the procedure just suggested. This borderline is at 3 U/l according to SCHMIDT (4) . In 4 different sera out of 1626 the activity of glutamate dehydrogenase, calculated by subtracting 0.3, was above 3 U/l, whereas the results were below 3 U/l when the correct individual blank values were used (Tab. 2). Thus, the estimated activity of glutamate dehydrogenase was falsely above the normal range in 0.25% of all human sera checked during this investigation. In these cases, however, the error was too low to seriously mislead the physician. For scientific studies the individual blank values should further be considered. Since a large serum volume is used for the glutamate dehydrogenase assay, the influence of sample volume on the enzyme activity was investigated. It was found with various sera that the glutamate dehydrogenase activity declines with increasing the sample volume (Tab. 3). This indicated that the proposed assay conditions are not optimal for serum samples. SCHMIDT (4) uses a 1:3.5 ratio between the volumes of the sample and the reaction mixture. If this ratio is changed to 1:6 and the end concentrations of the assay kept identical according to 1. c. (5) the variation within series batch increased significantly (Tab. 1). Because of this result we suggest that the recommendation of SCHMIDT (4) be followed. This appears to be a reasonable compromise for routine analytical purposes. The sample blank value was also lowered if the serum volume was increased (Tab. 3). The significance of this effect, which could be caused by an inhibitor of the side reaction present in human serum, requires further investigation. Further experiments were performed to investigate whether sera diluted with various solutions have higher activities than undiluted samples. Serum samples from 10 different patients were diluted 1+2 with Serum should be stored no longer than 5 days at 4°C 0.9% NaCl, Qualtrol and albumin solution. The before the glutamate dehydrogenase activity is measured glutamate dehydrogenase activity was determined in (Tab. 5). At the present time, Enzatrol is the only these preparations and in undiluted samples. The commercial available serum which is suitable for the results compared in Table 4 indicate that Qualtrol is quality control of the glutamate dehydrogenase detersuitable for the dilution of serum samples with gluta* mination. However, the activity of this enzyme declines mate dehydrogenase activities above 30 U/l. Both constantly, 'especially during the first hours (Tab. 5). Qualtrol and .the albumin solution contained no de-Therefore, we use Enzatrol for the control of precision tectable activity of glutamate dehydrogenase. 24 h after its reconstitution.
